This study evaluates the diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay in identifying Alzheimer's disease pathophysiology across three observational cohorts. Results demonstrate significant correlations between plasma phosphorylated tau 217 levels and Alzheimer's disease biomarkers, suggesting its potential as a reliable diagnostic tool in clinical settings, 2024.